Ling Zhi-8 mediates p53-dependent growth arrest of lung cancer cells proliferation via the ribosomal protein S7-MDM2-p53 pathway.
暂无分享,去创建一个
[1] C. Deisenroth,et al. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway , 2010, Oncogene.
[2] F. Sheu,et al. Polysaccharides PS-G and protein LZ-8 from Reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. , 2010, Journal of agricultural and food chemistry.
[3] I. Grummt,et al. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. , 2010, Annual review of pharmacology and toxicology.
[4] Yanping Zhang,et al. Signaling to p53: ribosomal proteins find their way. , 2009, Cancer cell.
[5] Yu-Chih Liang,et al. An immunomodulatory protein, Ling Zhi‐8, induced activation and maturation of human monocyte‐derived dendritic cells by the NF‐κB and MAPK pathways , 2009, Journal of leukocyte biology.
[6] X. Jacq,et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. , 2009, Molecular cell.
[7] G. Yen,et al. Inhibitory effects of ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. , 2009, Journal of agricultural and food chemistry.
[8] Cong-Zhao Zhou,et al. Crystal structure of LZ‐8 from the medicinal fungus Ganoderma lucidium , 2009, Proteins.
[9] P. Pandolfi,et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction , 2009, Nature Cell Biology.
[10] M. Oren,et al. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. , 2008, Molecular cell.
[11] L. Montanaro,et al. Nucleolus, ribosomes, and cancer. , 2008, The American journal of pathology.
[12] F. Sheu,et al. High processing tolerances of immunomodulatory proteins in Enoki and Reishi mushrooms. , 2008, Journal of agricultural and food chemistry.
[13] Ching-Tsan Huang,et al. Reishi immuno‐modulation protein induces interleukin‐2 expression via protein kinase‐dependent signaling pathways within human T cells , 2008, Journal of cellular physiology.
[14] W. Wang,et al. Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function , 2007, Oncogene.
[15] G. Wahl,et al. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.
[16] R. Paterson,et al. Ganoderma - a therapeutic fungal biofactory. , 2006, Phytochemistry.
[17] C.-Y. Chang,et al. Involvement of Bcl-XL deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells , 2006, Oncogene.
[18] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[19] Steven P. Gygi,et al. mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.
[20] Valérie Choesmel,et al. Nuclear export and cytoplasmic processing of precursors to the 40S ribosomal subunits in mammalian cells , 2005, The EMBO journal.
[21] E. Casanova,et al. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. , 2005, Molecular cell.
[22] D. Sliva,et al. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. , 2005, Biochemical and biophysical research communications.
[23] M. Dai,et al. Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5* , 2004, Journal of Biological Chemistry.
[24] D. Sliva,et al. Cellular and physiological effects of Ganoderma lucidum (Reishi). , 2004, Mini reviews in medicinal chemistry.
[25] M. Dai,et al. Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition , 2004, Molecular and Cellular Biology.
[26] Hui-Nan Zhang,et al. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. , 2004, Acta pharmacologica Sinica.
[27] D. Sliva,et al. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. , 2004, International journal of oncology.
[28] T. Allio,et al. Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.
[29] J. Milner,et al. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses , 2003, The EMBO journal.
[30] M. Kubbutat,et al. Regulation of HDM2 activity by the ribosomal protein L11. , 2003, Cancer cell.
[31] P. Pandolfi,et al. Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.
[32] K. Kang,et al. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF‐7 human breast cancer cell , 2002, International journal of cancer.
[33] David Tollervey,et al. The function and synthesis of ribosomes , 2001, Nature Reviews Molecular Cell Biology.
[34] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[35] C. Prives. Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.
[36] Luigi Naldini,et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.
[37] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[38] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[39] A. Hoitsma,et al. LING ZHI‐8: STUDIES OF A NEW IMMUNOMODULATING AGENT , 1995, Transplantation.
[40] P. Jardieu,et al. Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. , 1993, Cellular immunology.
[41] K. Kinzler,et al. Oncogenic forms of p53 inhibit p53-regulated gene expression , 1992 .
[42] S. Tanaka,et al. Molecular cloning of a cDNA and a gene encoding an immunomodulatory protein, Ling Zhi-8, from a fungus, Ganoderma lucidum. , 1991, The Journal of biological chemistry.
[43] S. Tanaka,et al. Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidium, having similarity to immunoglobulin variable regions. , 1989, The Journal of biological chemistry.
[44] J. Watanabe,et al. Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. , 1989, The Journal of biological chemistry.
[45] Y-M Lin,et al. Involvement of Bcl-X(L) deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells. , 2006, Oncogene.
[46] Robert J. White,et al. RNA polymerases I and III, growth control and cancer , 2005, Nature Reviews Molecular Cell Biology.